TD Asset Management Inc Reduces Stock Holdings in Teleflex Incorporated $TFX

TD Asset Management Inc decreased its stake in Teleflex Incorporated (NYSE:TFX) by 6.9% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 304,400 shares of the medical technology company’s stock after selling 22,400 shares during the quarter. TD Asset Management Inc owned about 0.69% of Teleflex worth $37,149,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of TFX. Banque Cantonale Vaudoise boosted its holdings in shares of Teleflex by 82.5% in the 4th quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock worth $31,000 after purchasing an additional 113 shares during the period. Hantz Financial Services Inc. boosted its holdings in shares of Teleflex by 248.8% in the 3rd quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock worth $34,000 after purchasing an additional 199 shares during the period. Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of Teleflex in the 3rd quarter worth approximately $35,000. V Square Quantitative Management LLC purchased a new position in shares of Teleflex in the 4th quarter worth approximately $37,000. Finally, Sound Income Strategies LLC purchased a new position in shares of Teleflex in the 4th quarter worth approximately $45,000. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Trading Down 1.7%

Shares of NYSE TFX opened at $129.90 on Friday. The company has a debt-to-equity ratio of 0.82, a current ratio of 2.55 and a quick ratio of 2.03. The stock has a market capitalization of $5.75 billion, a P/E ratio of -5.70, a price-to-earnings-growth ratio of 0.97 and a beta of 0.82. Teleflex Incorporated has a 1-year low of $100.18 and a 1-year high of $139.67. The business has a fifty day moving average price of $127.08 and a 200 day moving average price of $118.04.

Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 earnings per share for the quarter, topping analysts’ consensus estimates of $1.21 by $0.18. The firm had revenue of $548.30 million during the quarter, compared to analysts’ expectations of $536.91 million. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The firm’s quarterly revenue was up 32.3% on a year-over-year basis. During the same period in the prior year, the business posted $1.44 EPS. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Equities research analysts expect that Teleflex Incorporated will post 6.7 EPS for the current fiscal year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Monday, May 25th will be paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Friday, May 22nd. Teleflex’s dividend payout ratio is -5.96%.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on TFX. Mizuho set a $140.00 target price on Teleflex in a report on Friday, May 8th. Raymond James Financial reiterated an “outperform” rating and issued a $150.00 target price on shares of Teleflex in a report on Friday, May 8th. Wall Street Zen cut Teleflex from a “hold” rating to a “sell” rating in a report on Saturday, May 9th. Wells Fargo & Company lifted their target price on Teleflex from $130.00 to $138.00 and gave the stock an “equal weight” rating in a report on Friday, May 8th. Finally, Bank of America upgraded Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 price objective for the company in a report on Monday, April 13th. Three analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $144.00.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.